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none of us have extensive experience of using deep
vein, on two occasions I have attempted anastamosis
without the gusset, I have found difficulty in persuad-
ing a rather friable 11 mm or 12 mm deep vein to
stretch over an 18 mm or 20 mm diameter aorta. On
both occasions I found the tension sufficient to cause
small tears in the vein and I feel that the basic surgical
principle of not suturing under tension by inserting
the gusset to be a more comfortable option. Perhaps
I have just been unlucky with small veins and big
aortas.
R. A. Edmondson
King's College Hospital, London
doi:10.105 /ejvs.2002.1638, available online at
http://www.idealibrary.com on
Endoscopic Thoracic Sympathectomy
Sir,
The authors of this study1 may be surprised to learn
that the operation of Endoscopic Thoracic Sympa-
thectomy (ETS) was not invented in Vienna by Kux
but was first performed in England by Hughes in
1942.2 Is this another example of the British tradition of
allowing our inventions to be developed elsewhere?
The questions and answers in this survey show just
how far we have lagged behind the rest of the world:
 The procedure is now abbreviated to ETS.
 Double-lumen anaesthesia has been abandoned.
 Bilateral procedures are always performed.
 Vascular disorders rarely respond to ETS.
 The Kuntz nerve is not a cause of failure.
 Use of an infraclavicular port is uncommon.
 Isolated axillary hyperhidrosis is best treated by
Botox injection.
Support for all these statements comes from the 4th
International Symposium on Sympathetic Surgery
held in Finland in June 2001. (The proceedings have
been published in Annales Chirurgiae Volume 90,
No 3). Only two consultants and two trainees from
the U.K. attended this meeting. It was decided to form
an International Society for Sympathetic Surgery
(under the Presidency of Dr Christer Drott) which
will be formally launched at the next meeting in Erlan-
gen in 2003. I would encourage all U.K. surgeons
performing ETS to contact me so they may go on the
mailing-list for the society. Hopefully this would help
restore our proper place in the ETS community.
A. Cameron
Ipswich, U.K.
References
1 Khan AZ, Morgan, SC, Currie IC, Lewis P, Lewis DR. Current
Practice of Transthoracic Endoscopic Sympathectomy in the South
West of England: an E-mail Survey. Eur J Vasc Endovasc Surg 2001;
22: 373±375.
2 Hughes J. Endothoracic sympathectomy. Proc Roy Soc Med 1942;
35: 585±586.
No reply received
doi:10.105 /ejvs.2002.1637, available online at
http://www.idealibrary.com on
Systemic Effects of Intermittent Claudication
570 Correspondence
Eur J Vasc Endovasc Surg Vol 23, June 2002
3
3Sir,
The paper by Lewis et al.1 is of importance given the
relationship between exercise in claudicants and its
associated inflammatory response.2 However, there
are several important points to raise regarding the
methodology of assessment of the systemic effects of
claudication. The use of the urine albumin to creati-
nine ratio (UACR) may not be as useful an indicator
of systemic vascular permeability as previously
thought.3 The UACR is affected by both the endo-
thelial integrity of the renal glomerulus as well as
renal haemodynamic factors. In particular, any change
in renin or catecholamine levels will alter the transglo-
merular filtration pressure and hence microalbumin
excretion. As the relationship between creatinine ex-
cretion and albumin excretion is not linear, expressing
the rate of albumin excretion as the UACR cannot
adjust fully for potential changes in renal haemo-
dynamic factors. Hence, changes to the UACR in this
study may simply be a reflection of less catecholamine
release commensurate with less pain from claudica-
tion following successful angioplasty. Mattei et al.
made a detailed analysis of the relationship between
microalbuminuria and renal haemodynamics.4 They
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Graft Injection
Sir,
We read with interest Naylor et al.'s audit of complex
wound and graft infections.1 Graft infections,
although uncommon, remain potentially catastrophic
and any research to improve their prevention and
management is welcome. Whilst this was a very wel-
come study, the strengths of any conclusions were
limited due to a number of weaknesses:
(1) Although the study was multi-centric the number
of centres participating and the proportion of
patients from each centre were not stated. This
introduces additional bias to a study, which from
the outset was subject to reporting bias.
(2) Patients with type II and type III infections were
included in the study as complex wound infec-
tions despite Szilagyi's original paper which states
that grade II infections healed promptly without
significant sequelae. Perhaps only grade III infec-
tions should be considered as complex?2
(3) The definition of graft infection is not included in
the paper other than that the diagnosis was made
on clinical or radiological grounds. Furthermore,
ten patients (13%) with a wound infection had no
microbiology data recorded. These patients should
not have been included in the study as we do not
know if their MRSA status (they appear to have
been included in the MRSA negative group).
(4) The method (simple swab or aspiration), timing
(pre or post antibiotics) and number of wound
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3found that renal vasoconstriction at the level of the
efferent and afferent arteriole is associated with micro-
albuminuria. They also state that the main haemody-
namic characteristic leading to increased renal
vascular resistance is a rise in blood pressure.
We have similar concerns with regard to the total
antioxidant capacity (TAC) assay. This assay only
measures the chain-breaking antioxidants such as
urate, vitamin C and vitamin E. Whether measure-
ment of chain breaking antioxidants is a reliable
indicator of oxidant stress as a whole remains to be
determined. However, the principal problem with
the TAC assay is its great dependence on plasma
urate level.5 This represents a methodological prob-
lem as during ischaemia-reperfusion events uric acid
is produced as a by-product of hypoxanthine metab-
olism. Therefore, a fall in TAC may reflect decreased
uric acid formation due to less hypoxanthine meta-
bolism (i.e. due to reduced oxidant stress) or, paradox-
ically, consumption of uric acid as an antioxidant (i.e.
due to increased oxidant stress).
Given that markers such as TAC, UACR and vWF
may be affected by factors such as antihypertensive
treatment, degree of diabetic control and smoking sta-
tus, it is important in a very small study such as this to
know whether such parameters changed during the
course of the study. Could the authors, therefore, com-
ment on the time interval between the pre angioplasty
assessment and the post angioplasty assessment
and detail how many of the patients received any
alteration to their antihypertensive treatment or cut-
down/gave-up smoking in this time period?
Could the authors clarify the statistical test used to
determine the statistically significant fall that they
found in TAC after angioplasty. The difference in
TAC from pre to post angioplasty is extremely small,
yet they have shown that it is statistically significant at
the 5 time points measured. Did they correct the p
value appropriately for repeated measures using, for
example, the Bonferroni correction?
E. P. L. Turton and D. J. A. Scott
Dept. of Vascular Surgery,
St. James's University Hospital, Leeds, U.K.
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